5 Plaque Psoriasis Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Plaque Psoriasis Studies in Phoenix

NCT07116967Recruiting

Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis...

Phoenix, AZPHASE33,040 participantsBristol-Myers Squibb

View Study Details

NCT06979453Recruiting

A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis

The purpose of this study is to evaluate the efficacy, safety, and drug levels of Deucravacitinib (BMS-986165) in adolescent participants with moderate to severe plaque psoriasis...

Phoenix, AZPHASE3366 participantsBristol-Myers Squibb

View Study Details

NCT07449702Recruiting

An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis

An open-label extension (OLE) study to evaluate the long-term safety and efficacy of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis, who previously participated in an Oruka Th...

Phoenix, AZPHASE2240 participantsOruka Therapeutics, Inc.

View Study Details

NCT06857942Recruiting

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity o...

Phoenix, AZPHASE4200 participantsEli Lilly and Company

View Study Details

NCT07474792Recruiting

Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis

This is a multicenter, randomized, double-blinded, placebo-controlled, dose-range finding study to evaluate the efficacy and safety of ORKA-002 in adult participants with moderate-to-severe plaque pso...

Phoenix, AZPHASE2160 participantsOruka Therapeutics, Inc.

View Study Details

About Plaque Psoriasis Clinical Trials in Phoenix

Plaque psoriasis is the most common form of psoriasis, characterized by raised, red patches covered with silvery-white scales. It can appear anywhere on the body and affects about 80% of people with psoriasis. Treatment includes topical therapies, phototherapy, and systemic medications including biologics.

There are currently 5 plaque psoriasis clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 4,006 participants. Research is being sponsored by Bristol-Myers Squibb, Oruka Therapeutics, Inc., Eli Lilly and Company. Clinical trial participation is free and participants receive study-related medical care at no cost.

Plaque Psoriasis Clinical Trials in Phoenix — FAQ

Are there plaque psoriasis clinical trials in Phoenix?

Yes, there are 5 plaque psoriasis clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What plaque psoriasis treatments are being tested?

The 5 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for plaque psoriasis.

Data updated October 17, 2026 from ClinicalTrials.gov